« Back
Carisma Therapeutics Presents Data at the AACR Tumor Immunology and Immunotherapy Meeting 2019
Carisma Therapeutics Presents Data at the AACR Tumor Immunology and Immunotherapy Meeting 2019
Nov 18, 2019
Carisma Therapeutics Senior Scientist Konrad Gabrusiewicz, PhD, will present an abstract titled “CT-0508, a novel CAR macrophage product directed against HER2, promotes a pro-inflammatory tumor microenvironment” at the AACR Tumor Immunology and Immunotherapy 2019 meeting taking place November 17-20 in Boston, MA. For full conference agenda, see here.